Kinetic studies of FR-1, a growth factor-inducible aldo-keto reductase

被引:42
|
作者
Srivastava, S
Harter, TM
Chandra, A
Bhatnagar, P
Srivastava, SK
Petrash, JM
机构
[1] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA
[3] Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77550 USA
关键词
D O I
10.1021/bi9804333
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Murine fibroblasts cultured in the presence of fibroblast growth factor-1 express relatively high levels of FR-1, a similar to 36 kDa protein related to the aldo-keto reductase superfamily [Donohue, P. J., Alberts, G. F., Hampton, B. S., Winkles, J.A. (1994) J. Biol. Chem. 269, 8604-8609]. While the crystal structure of FR-1 shows striking homology with:human aldose reductase [Wilson, D. K., Nakano, T., Petrash, J. M., Quiocho, F. A. (1995) Biochemistry 34, 14323-14330], an enzyme linked to the pathogenesis of diabetic complications, the physiological role of FR-1 is not known. We show that FR-1 is capable of reducing a broad range of aromatic and aliphatic aldehydes, :including the abundant and highly reactive lipid-derived aldehyde 4-hydroxy-2-nonenal (HNE; K-m approximate to 9 mu M). However, in the absence of coenzyme, HNE caused a time-dependent inactivation of FR-1. Results from electrospray ionization-mass spectrometry and Edman-degradation of peptides derived from HNE-modified FR-1 were consistent with formation of a Michael adduct at Cys298. This was confirmed with a C298S mutant, which was resistant to HNE-induced inactivation. Since steady-state K-m values determined with alkanals, alpha,beta-unsaturated alkenals, alkadienals, and 4-hydroxyalkenals fall within their physiological concentrations, lipid-derived aldehydes appear to be potential in vivo substrates for FR-1.
引用
收藏
页码:12909 / 12917
页数:9
相关论文
共 50 条
  • [31] Crystallization and aldo-keto reductase activity of Gcy1p from Saccharomyces cerevisiae
    Hur, E
    Wilson, DK
    ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 2000, 56 : 763 - 765
  • [32] Perspective on the Structural Basis for Human Aldo-Keto Reductase 1B10 Inhibition
    Ruiz, Francesc Xavier
    Pares, Xavier
    Farres, Jaume
    METABOLITES, 2021, 11 (12)
  • [33] Aldo-Keto Reductase 1C15 Characterization and Protection in Ischemic Brain Injury
    Yang, Tuo
    Li, Qianqian
    Fadoul, George
    Alraqmany, Nour
    Ikonomovic, Milos
    Zhang, Feng
    ANTIOXIDANTS, 2023, 12 (04)
  • [34] Aldo-keto reductase 1C3 regulates prostaglandin signaling in breast cancer
    Byrns, Michael C.
    Lee, Seon Hwa
    Duan, Ling
    Blair, Ian A.
    Penning, Trevor M.
    CHEMICAL RESEARCH IN TOXICOLOGY, 2007, 20 (12) : 1997 - 1997
  • [35] Structure and promoter characterization of aldo-keto reductase family 1 B10 gene
    Liu, Ziwen
    Zhong, Linlin
    Krishack, Paulette A.
    Robbins, Sarah
    Cao, Julia X.
    Zhao, Yupei
    Chung, Stephen
    Cao, Deliang
    GENE, 2009, 437 (1-2) : 39 - 44
  • [36] The Expression and Clinical Significance of Aldo-Keto Reductase 1 Member B1 in Gastric Carcinoma
    Li, Xin
    Yang, Jinzu
    Gu, Xiaoqiang
    Xu, Jiahua
    Li, Hongwei
    Qian, Jianxin
    Chen, Ling
    DNA AND CELL BIOLOGY, 2020, 39 (07) : 1322 - 1327
  • [37] Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism
    Rizner, Tea Lanisnik
    Penning, Trevor M.
    STEROIDS, 2014, 79 : 49 - 63
  • [38] Aldo-keto reductase 1C2 fails to metabolize doxorubicin and daunorubicin in vitro
    Takahashi, Ryan H.
    Bains, Onkar S.
    Pfeifer, Tom A.
    Grigliatti, Thomas A.
    Reid, Ronald E.
    Riggs, K. Wayne
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (06) : 991 - 994
  • [39] Enzymatic properties of a member (AKR1C19) of the aldo-keto reductase family
    Ishikura, S
    Horie, K
    Sanai, M
    Matsumoto, K
    Hara, A
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (06) : 1075 - 1078
  • [40] Aldo-Keto Reductase 1B7, a New and Independent Marker for Renin Cells
    Lin, Eugene
    Lopez, Maria Luisa S. Sequeira
    Pentz, Ellen S.
    Castellanos-Rivera, Ruth M.
    Gomez, R. Ariel
    HYPERTENSION, 2011, 58 (05) : E83 - E83